Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy E Davidson

Showing results (1-10 of 285) with videos related to

Pageof 29
Sort By:
Clinical Breast Cancer|November 19, 2002
Ongoing US cooperative group trials using taxanes in the adjuvant settingNancy E Davidson
The Lancet. Oncology|June 2, 2007
The maturation of medical oncologyNancy E Davidson
Endocrine-Related Cancer|April 10, 2016
Serendipity and purposeNancy E Davidson
JAMA Oncology|November 24, 2017
Incident Cancer in Cancer Survivors-When Cancer Lurks in the BackgroundNancy E Davidson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Martin D. Abeloff, MDNancy E Davidson
Oncology (Williston Park, N.Y.)|May 22, 2013
Fifteen years of anti-HER2 therapyNancy E Davidson
Oncology (Williston Park, N.Y.)|June 20, 2008
Tracking 35 years of progress against breast cancerNancy E Davidson
Oncology (Williston Park, N.Y.)|June 30, 2011
HER2-targeted therapies: how far we've come--and where we're headedNancy E Davidson
Journal of Oncology Practice|January 14, 2016
Conquering Metastatic Breast CancerNancy E Davidson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2022
In It for the Long Haul: Long-Term Benefit With Adjuvant Endocrine Therapy for Premenopausal Women With Early-Stage Steroid Receptor-Positive Breast CancerNancy E Davidson
Pageof 29

Showing results (1-10 of 285) with videos related to

Sort By:
Pageof 29
Clinical Breast Cancer|November 19, 2002
Ongoing US cooperative group trials using taxanes in the adjuvant settingNancy E Davidson
The Lancet. Oncology|June 2, 2007
The maturation of medical oncologyNancy E Davidson
Endocrine-Related Cancer|April 10, 2016
Serendipity and purposeNancy E Davidson
JAMA Oncology|November 24, 2017
Incident Cancer in Cancer Survivors-When Cancer Lurks in the BackgroundNancy E Davidson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Martin D. Abeloff, MDNancy E Davidson
Oncology (Williston Park, N.Y.)|May 22, 2013
Fifteen years of anti-HER2 therapyNancy E Davidson
Oncology (Williston Park, N.Y.)|June 20, 2008
Tracking 35 years of progress against breast cancerNancy E Davidson
Oncology (Williston Park, N.Y.)|June 30, 2011
HER2-targeted therapies: how far we've come--and where we're headedNancy E Davidson
Journal of Oncology Practice|January 14, 2016
Conquering Metastatic Breast CancerNancy E Davidson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2022
In It for the Long Haul: Long-Term Benefit With Adjuvant Endocrine Therapy for Premenopausal Women With Early-Stage Steroid Receptor-Positive Breast CancerNancy E Davidson
Pageof 29